Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric Oxygen Therapy for Chronic Mild Traumatic Brain Injury / Persistent Post-Concussion Syndrome
NCT02089594Phase 3Unknown
- Sponsor
- Louisiana State University Health Sciences Center
- Start
- May 2014
- Primary completion
- Mar 2018
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of hyperbaric oxygen therapy in Post-concussion syndrome (PCS) and traumatic brain injury (TBI) (2 arms), sponsored by Louisiana State University Health Sciences Center. Primary endpoints: Working Memory and Neurobehavioral Symptom Inventory. Status: unknown.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
Post-concussion syndrome (PCS)traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02089594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02089594.